학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 160건 | 목록 1~20
Academic Journal
Elisei R; Endocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.; Wirth LJ; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Capdevila J; Medical Oncology Department, Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain.; Hoff AO; Department of Endocrinology, Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo and Instituto D' OR de Pesquisa e Ensino, São Paulo, Brazil.; Tahara M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.; Sherman EJ; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Hu MI; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.; Ge MH; Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital, Hangzhou, China.; Wadsley J; Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.; Vaisman F; Endocrinologia Oncológica, Instituto Nacional do Cancer, Rio de Janeiro, Brazil.; Kopeckova K; Department of Oncology, 2nd Faculty of Medicine of Charles University and Motol University Hospital, Prague, Czech Republic.; Krajewska J; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.; Olvera D; Eli Lilly and Company, Indianapolis, Indiana, USA.; Churchill C; Eli Lilly and Company, Indianapolis, Indiana, USA.; Maeda P; Eli Lilly and Company, Indianapolis, Indiana, USA.; Gilligan AM; Eli Lilly and Company, Indianapolis, Indiana, USA.; Lin Y; Eli Lilly and Company, Indianapolis, Indiana, USA.; Payakachat N; Eli Lilly and Company, Indianapolis, Indiana, USA.; Robinson B; Sydney Medical School, University of Sydney, Sydney, Australia.; Hadoux J; Service d'Oncologie Endocrinienne, Département d'imagerie, Gustave Roussy and ENDOCAN-TUTHYREF Network, Villejuif, France.; Brose MS; Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Publisher: Mary Ann Liebert Publishers Country of Publication: United States NLM ID: 9104317 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-9077 (Electronic) Linking ISSN: 10507256 NLM ISO Abbreviation: Thyroid Subsets: MEDLINE
Academic Journal
Capdevila J; Gastrointestinal and Endocrine Tumor Unit, Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), IOB Quiron-Teknon, Barcelona, Spain.; Krajewska J; Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.; Hernando J; Vall d'Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Robinson B; Department of Medicine, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.; Sherman SI; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Jarzab B; Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland.; Lin CC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Vaisman F; Department of Endocrinology, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.; Hoff AO; Department of Endocrinology, Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil.; Hitre E; Department of Medical Oncology, The Multidisciplinary Head and Neck Cancer Center, Országos Onkológiai Intézet, Budapest, Hungary.; Bowles DW; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Williamson D; Department of Biostatistics, Exelixis, Inc., Alameda, California, USA.; Levytskyy R; Department of Medical Affairs, Exelixis, Inc., Alameda, California, USA.; Oliver J; Department of Clinical Development, Exelixis, Inc., Alameda, California, USA.; Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Brose MS; Department of Medical Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publisher: Mary Ann Liebert Publishers Country of Publication: United States NLM ID: 9104317 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-9077 (Electronic) Linking ISSN: 10507256 NLM ISO Abbreviation: Thyroid Subsets: MEDLINE
Academic Journal
Subbiah V; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Hu MI; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Mansfield AS; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Taylor MH; Developmental Cancer Therapeutics Laboratory, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon, USA.; Schuler M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Zhu VW; Department of Medicine, University of California Irvine, Orange, California, USA.; Hadoux J; Department of Endocrine Oncology, Gustave Roussy, Villejuif, France.; Curigliano G; Clinical Division of Early Drug Development, European Institute of Oncology, IRCCS, Milano, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.; Wirth L; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, Massachusetts, USA.; Gainor JF; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, Massachusetts, USA.; Alonso G; Early Drug Development Unit, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.; Adkins D; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.; Godbert Y; Nuclear Medicine and Thyroid Oncology Department, Bergonié Institute Cancer Center, Bordeaux, France.; Ahn MJ; Department of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Cassier PA; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.; Lin CC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Zalutskaya A; Blueprint Medicines Corporation, Cambridge, Massachusetts, USA.; Barata T; F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Trask P; Genentech, Inc., South San Francisco, California, USA.; Scalori A; F. Hoffmann-La Roche Ltd., Welwyn Garden City, United Kingdom.; Bordogna W; F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Heinzmann S; F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Brose MS; Departments of Otorhinolaryngology; Head and Neck Surgery, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publisher: Mary Ann Liebert Publishers Country of Publication: United States NLM ID: 9104317 Publication Model: Print Cited Medium: Internet ISSN: 1557-9077 (Electronic) Linking ISSN: 10507256 NLM ISO Abbreviation: Thyroid Subsets: MEDLINE
Academic Journal
Brose MS; Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA.; Westphalen CB; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Comprehensive Cancer Center (CCC Munich LMU), LMU University Hospital Munich, Munich, Germany.; Pan X; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ.; Bernard-Gauthier V; Bayer Pharmaceuticals, Inc, Toronto, ON, Canada.; Kurtinecz M; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ.; Guo H; Bayer Pharmaceuticals, Inc, Toronto, ON, Canada.; Aris V; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ.; Brett NR; PPD, part of Thermo Fisher Scientific, Montreal, QC, Canada.; Majdi A; Bayer HealthCare SAS, La Garenne-Colombes, France.; Subbiah V; Sarah Cannon Research Institute, Nashville, TN.; Pennell NA; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.; Kehl KL; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Drilon A; Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Waguespack SG; 1The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Cabanillas ME; 1The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Bernard-Gauthier V; 2Bayer Pharmaceuticals, Inc., Toronto, Ontario, Canada.; Assar N; 3Patient Author.; 4ThyCa: Thyroid Cancer Survivors' Association, Inc., Olney, Maryland, USA.; Bloom G; 3Patient Author.; 4ThyCa: Thyroid Cancer Survivors' Association, Inc., Olney, Maryland, USA.; Esparza R; 3Patient Author.; Brose MS; 5Sidney Kimmel Cancer Center of Jefferson University Health, Philadelphia, Pennsylvania, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: In Process; MEDLINE
Academic Journal
Regnault A; Modus Outcomes, a THREAD Company, Lyon, France.; Bunod L; Modus Outcomes, a THREAD Company, Lyon, France.; Loubert A; Modus Outcomes, a THREAD Company, Lyon, France.; Brose MS; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.; Hess LM; Eli Lilly and Company, Lilly Corporate Center DC 1730, Indianapolis, IN, 46285, USA.; Maeda P; Eli Lilly and Company, Lilly Corporate Center DC 1730, Indianapolis, IN, 46285, USA.; Lin Y; Eli Lilly and Company, Lilly Corporate Center DC 1730, Indianapolis, IN, 46285, USA.; Speck RM; Eli Lilly and Company, Lilly Corporate Center DC 1730, Indianapolis, IN, 46285, USA.; Gilligan AM; Eli Lilly and Company, Lilly Corporate Center DC 1730, Indianapolis, IN, 46285, USA.; Payakachat N; Eli Lilly and Company, Lilly Corporate Center DC 1730, Indianapolis, IN, 46285, USA. npayakachat@lilly.com.
Publisher: Springer International Publishing Country of Publication: Germany NLM ID: 101722688 Publication Model: Electronic Cited Medium: Internet ISSN: 2509-8020 (Electronic) Linking ISSN: 25098020 NLM ISO Abbreviation: J Patient Rep Outcomes Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Brose, Marcia S
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어